Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05130541 · ClinicalTrials.gov registry record · NA
Proning Early in Awake COVID-19 Hypoxic Respiratory Failure (PREACHR) Study
A NA study of COVID-19 and Respiratory Failure, sponsored by New York Hospital Queens.
- Completed
- Registry status
- NA
- Development phase
- 219
- Enrollment target
- 1
- Study location
NCT05130541: Completed NA study of COVID-19 and Respiratory Failure, sponsored by New York Hospital Queens.
NCT05130541 is a NA study of COVID-19 and Respiratory Failure that has completed, run by New York Hospital Queens. The registered enrollment target is 219 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05130541, a NA study of COVID-19 and Respiratory Failure, has completed, sponsored by New York Hospital Queens.
- COMPLETED
- Registry status
- NA
- Development phase
- 219 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of this proposal is to study whether proning, a technique that has previously been shown to improve lung function in patients with acute respiratory distress syndrome (ARDS), can prevent those with mild to moderate symptoms of COVID-19 from progressing to severe disease when initiated early, thereby averting intubation, reducing hospitalization, and, ultimately, decreasing mortality.
Primary Outcome
All-cause mortality
Conditions Studied
Interventions
- OTHER Supportive Care
- BEHAVIORAL Proning
Study Locations (1)
New York
- New York Presbyterian Queens - Flushing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2020-06-01 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
What the finished NCT05130541 record still lists
NCT05130541 is an interventional study that assigns participants to a tested intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which Supportive Care is the first listed.
NCT05130541 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05130541 about?
NCT05130541 is a clinical study titled "Proning Early in Awake COVID-19 Hypoxic Respiratory Failure (PREACHR) Study". The aim of this proposal is to study whether proning, a technique that has previously been shown to improve lung function in patients with acute respiratory distress syndrome (ARDS), can prevent those with mild to moderate symptoms of COVID-19 from progressing to severe disease when initiated early,...
What is the current status of trial NCT05130541?
This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2020-06-01. Estimated completion is 2021-05-01.
What conditions does trial NCT05130541 study?
This clinical trial studies the following conditions: COVID-19, Respiratory Failure.
What interventions are being tested in trial NCT05130541?
The interventions under investigation include: Supportive Care (OTHER), Proning (BEHAVIORAL).
Who is sponsoring clinical trial NCT05130541?
This trial is sponsored by New York Hospital Queens, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05130541 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05130541's enrollment target sits among peer trials
219 157th of 298 higher than 142 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI